Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Learn how wealth creation through diversified investments can maximize your returns. Build a strong financial future now.
25,092 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
CrowdStrike just split stock, turning a high-priced share into four easier-to-access pieces. A lower price can spark ...
Yield Guild Games is closing its YGG Play publishing arm and cutting 35 jobs as it pivots to artificial intelligence....
Bitcoin climbs toward new highs as Coinbase faces regulatory headlines. This piece breaks down what it means for mass...
Uber stock has slipped about 12% in three months, trading near $74 after a strong run. This article breaks down what’...
Income-focused investing is making waves in 2026. This high-yielding dividend beating ETF has shown resilience as bro...
Investors weigh Oxford Industries' next moves as oxford (oxm) 2025 earnings hinge on tariff costs, brand mix, and a b...
When the S&P 500 keeps climbing, many wonder if it’s time to jump in. This guide explains what history shows, how to ...
Alphabet raising $84.75 billion marks a bold turn in how tech giants fund AI bets. This article breaks down what it c...
A feud in late-night TV isn’t just talk. It can echo through stocks, regulator moves, and your budget. Learn how to s...
In July, investors are weighing recession risks against reliable income. This guide highlights three dividend staples...